Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-Human CD80/B7-1 Monoclonal Antibody (1A690) (HW630025)

Anti-Human CD80/B7-1 Monoclonal Antibody (1A690)
Anti-Human CD80/B7-1 Monoclonal Antibody (1A690)
  • icon
Price(USD):
Spec:
  • 20ug
  • 50ug
  • 100ug
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HW630025
Description
Anti-Human CD80/B7-1 Monoclonal Antibody (1A690) [1A690] (HW630025) is a mouse monoclonal antibody detecting CD80 in ELISA, IHC, WB. Suitable for Human.
Highlights
  • Recombinant — Superior batch-to-batch reproducibility with defined sequences.
  • Multi-Application — Validated across multiple applications.
Species reactivityHuman
ApplicationsELISA, IHC, WB
Host speciesMouse
IsotypeIgG
Clone ID1A690
Clonality Monoclonal
Immunogen E. coli - derived recombinant human CD80/B7-1 (Val35-Asn242).
Target T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, B7, CD80, CD80
Purification Protein A/G purified from cell culture supernatant.
Accession P33681
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background

T-lymphocyte activation antigen CD80 (B7-1) is a ~33 kDa protein. Costimulatory molecule that belongs to the immunoglobulin superfamily that plays an important role in T-lymphocyte activation. Acts as the primary auxiliary signal augmenting the MHC/TCR signal in naive T-cells by acting as a ligand for the CD28 receptor which is constitutively expressed on the cell surface of T-cells. In turn, activates different signaling pathways such as NF-kappa-B or MAPK leading to the production of different cytokines. Also acts as an inhibitor of T-cell activation by acting as a ligand for CTLA4, a decoy receptor, thereby blocking CD28-mediated T-cell priming. In addition, CD28/CD80 costimulatory signal stimulates glucose metabolism and ATP synthesis of T-cells by activating the PI3K/Akt signaling pathway.

1. Lu, B. et al. (2024) Acta pharmacologica Sinica 45, 1214-1223. PMID: 38467718
2. Collins, AV. et al. (2002) Immunity 17, 201-10. PMID: 12196291
3. Boulougouris, G. et al. (1999) Journal of immunology (Baltimore, Md. : 1950) 163, 1809-16. PMID: 10438913
4. Vandenborre, K. et al. (1999) Immunology 98, 413-21. PMID: 10583602
5. Stamper, CC. et al. (2001) Nature 410, 608-11. PMID: 11279502
6. Frauwirth, KA. et al. (2002) Immunity 16, 769-77. PMID: 12121659
7. Kennedy, A. et al. (2023) The EMBO journal 42, e111556. PMID: 36727298
Note For research use only.
Images
  • Anti-Human CD80/B7-1 Monoclonal Antibody (1A690)

    SDS-PAGE

    SDS-PAGE for Anti-Human CD80/B7-1 Monoclonal Antibody (1A690)

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list